The estimated Net Worth of Thomas J.W. Dittrich is at least $7.5 Milión dollars as of 21 May 2014. Thomas Dittrich owns over 4,130 units of AMGEN stock worth over $7,496,816 and over the last 14 years Thomas sold AMGN stock worth over $0.
Thomas has made over 4 trades of the AMGEN stock since 2012, according to the Form 4 filled with the SEC. Most recently Thomas exercised 4,130 units of AMGN stock worth $233,923 on 21 May 2014.
The largest trade Thomas's ever made was exercising 32,150 units of AMGEN stock on 31 July 2012 worth over $2,098,752. On average, Thomas trades about 3,116 units every 38 days since 2010. As of 21 May 2014 Thomas still owns at least 22,719 units of AMGEN stock.
You can see the complete history of Thomas Dittrich stock trades at the bottom of the page.
Thomas's mailing address filed with the SEC is ONE AMGEN CENTER DRIVE, M/S 28-5-C, THOUSAND OAKS, CA, 91320.
Over the last 21 years, insiders at AMGEN have traded over $219,663,137 worth of AMGEN stock and bought 8,904 units worth $919,219 . The most active insiders traders include Robert Eckert, Kevin W Sharer a Ellen Jamison Kullman. On average, AMGEN executives and independent directors trade stock every 35 days with the average trade being worth of $8,732,261. The most recent stock trade was executed by Nancy A. Grygiel on 3 May 2024, trading 2,117 units of AMGN stock currently worth $662,812.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
AMGEN executives and other stock owners filed with the SEC include: